Mindray taps Ede as new VP

Mindray Medical International Limited, a developer, manufacturer and marketer of medical devices, has appointed Ronald Ede as group vice president of international operations, effective June 25th.

Ede's primary responsibilities will be to oversee international operations, with a focus on Mindray's integration of Datascope's patient monitoring device business, which Mindray acquired in May 2008, according to the Shenzhen, China-based company.

Ede has served as an independent director on Mindray's board and several committees since Mindray's initial public offering in September 2006, Mindray said. The company also noted that Ede will continue to serve on the board as a director, but will not continue to serve on committees that require director independence.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.